Via β-adrenoceptors, stimulation of extrasplenic sympathetic nerve fibers inhibits lipopolysaccharide-induced TNF secretion in perfused rat spleen
Introduction
Since the first immunohistochemical studies of sympathetic nerves in the vicinity of immune cells in the spleen (for review, Bellinger et al., 2001), the functional interplay of these nerves and immune cells in the spleen has been described in several reports Straub et al., 1998b, Elenkov et al., 2000, Madden, 2001. Most often norepinephrine (NE) has been in the focus of experiments in order to study the functional interaction between sympathetic nerves and local immune cells. We previously described the modulation of splenic IL-6 secretion by locally released NE, opioids, neuropeptide Y (NPY), ATP, and adenosine using a spleen slice microsuperfusion technique Straub et al., 1997, Straub et al., 2000b, Straub et al., 2002. With respect to NPY and adenosine, features of co-transmission with NE for regulation of IL-6 secretion were observed Straub et al., 2000b, Straub et al., 2002. Furthermore, IL-6 secreting cells in these spleen slices are most probably macrophages because treatment of mice with clodronate liposomes, which destroys splenic macrophages but no other splenic cells, abolished IL-6 secretion from spleen slices (Straub et al., 1998a). In further experiments, the role of sympathetic modulation of splenic TNF secretion was scrutinized by using a highly potent monoclonal anti-TNF antibody and TNF receptor knock out mice (Straub et al., 2000a). From these studies, a complex picture of neuroimmunomodulation appears according to which regulation of IL-6 secretion depends on prior modulation of TNF secretion (Straub et al., 2000a).
Since experiments with spleen slices do not completely reflect investigations of an entire organ, our earlier results possibly cannot be compared to the outcome of perfusion experiments due to important factors such as (A) direct influence of the electrical current on macrophages, (B) uncontrolled medium flow through splenic tissue (in comparison to vessels), (C) another type of exchange between the interstitial and intravascular space, (D) missing modulation of endothelial cells by shear stress, (E) lack of vascular constriction and dilation, and many others. In order to get a more integral picture of sympathetic modulation of splenic cytokine secretion, perfusion experiments were carried out. At an early and late time point in relation to administration of lipopolysaccharide (LPS), splenic sympathetic nerve fibers were electrically stimulated far away from immunocompetent cells outside the spleen. These studies should add to the knowledge of neuroimmunomodulation of early cytokine secretion in the spleen.
Section snippets
Animals
Male CD-Rats were purchased from Charles River (Sulzfeld, Germany) and housed at 22 °C and 70% air humidity on a 12-h light–dark cycle with free access to water and standard food. At the time of experiment, they weighed approximately 200 g. Experiments were performed according to the Guidelines for Animal Experimentation (Government of the Oberpfalz, AZ 621-2531.1-19/00).
Perfusion of the spleen
Animals were anesthetized using 12 mg/kg ketamine and 1 mg/kg xylazine. The spleen was prepared according to a previously
Catecholamine release from perfused rat spleen
Norepinephrine was released from the isolated perfused spleen in a frequency-dependent manner (Fig. 2A), and maximum release was observed at 10 Hz. Thus, in all further experiments stimulation was performed with 10 Hz. Norepinephrine secretion was accompanied by simultaneous release of epinephrine and dopamine (Fig. 2B). The time-concentration curve of norepinephrine and epinephrine were very similar (Fig. 2B), whereas the maximum of dopamine release appeared 1 h later (Fig. 2B). Concentration
Discussion
These studies in perfused rat spleen were carried out in order to investigate the early and late influence of electrical stimulation of splenic sympathetic nerves on spontaneous and LPS-induced secretion of IL-6 and TNF. These two cytokines were selected because we wanted to compare our earlier experimental conditions in mice spleen slices, which focused on IL-6 and TNF, with extrasplenic stimulation of sympathetic nerves under perfusion conditions Straub et al., 1997, Straub et al., 1998a,
Acknowledgments
This study was supported by the Deutsche Forschungsgemeinschaft (Str 511/9-1). We thank Stefan Grüne for his technical advice concerning perfusion experiments.
References (38)
- et al.
Immunoregulation mediated by the sympathetic nervous system
Cell. Immunol.
(1979) - et al.
Suppression of splenic macrophage interleukin-1 secretion following intracerebroventricular injection of interleukin-1 beta: evidence for pituitary-adrenal and sympathetic control
Cell. Immunol.
(1991) - et al.
The mechanism of cAMP-induced glucocorticoid receptor expression. Correlation to cellular glucocorticoid response
J. Biol. Chem.
(1989) - et al.
Ligand-independent activation of the glucocorticoid receptor by beta2-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells
J. Biol. Chem.
(1999) - et al.
Interleukin-1 beta induced corticosterone elevation and hypothalamic NE depletion is vagally mediated
Brain Res. Bull.
(1995) - et al.
Cyclic AMP-dependent protein kinase promotes glucocorticoid receptor function
J. Biol. Chem.
(1986) - et al.
The effect of norepinephrine on endotoxin-mediated macrophage activation
J. Neuroimmunol.
(1991) - et al.
Regulation of macrophage-derived tumor necrosis factor production by modification of adrenergic receptor sensitivity
J. Neuroimmunol.
(1995) - et al.
Norepinephrine: a messenger from the brain to the immune system
Immunol. Today
(2000) - et al.
Interaction between glucocorticoids and beta2-agonists: alpha and beta glucocorticoid-receptor mRNA expression in human bronchial epithelial cells
Biochem. Pharmacol.
(1998)
Modulation of glucocorticoid receptor activity by cyclic nucleotides and its implications on the regulation of human skin fibroblast growth and protein synthesis
Biochim. Biophys. Acta
Norepinephrine, the beta-adrenergic receptor, and immunity
Brain Behav. Immun.
Neuroimmune control of interleukin-6 secretion in the murine spleen. Differential-adrenergic effects of electrically released endogenous norepinephrine under various endotoxin conditions
J. Neuroimmunol.
Dialogue between CNS and immune system in lymphoid organs
Immunol. Today
Immunoregulation of IL-6 secretion by endogenous and exogenous adenosine and by exogenous purinergic agonists in splenic tissue slices
J. Neuroimmunol.
Phenylethanolamine N-methyltransferase mRNA in rat spleen and thymus
Neurosci. Lett.
Innervation of lymphoid organs-association of nerves with cells of the immune system and their implications in disease
Lipopolysaccharide induces sickness behaviour in rats by a vagal mediated mechanism
C. R. Acad. Sci., Ser. 3 Sci. Vie
Modulation of glucocorticoid receptor expression in human articular chondrocytes by cAMP and prostaglandins
J. Rheumatol., Suppl.
Cited by (64)
Subthreshold splenic nerve stimulation prevents myocardial Ischemia-Reperfusion injury via neuroimmunomodulation of proinflammatory factor levels
2023, International ImmunopharmacologyCitation Excerpt :SpNS is proposed as an emerging therapeutic strategy for the treatment of immune-related diseases via activation of the CAP. Either ex vivo or in vivo, electrical stimulation of the SpN reduces cytokine production in response to inflammatory stimulus challenge [20,26,44,45]. In prior studies, the vagus nerve was identified as a potential therapeutic target for many cardiovascular diseases [46,47], and the anti-inflammatory effects of vagus nerve stimulation rely on the SpN [14,48].
Role of C1 neurons in anti-inflammatory reflex: Mediation between afferents and efferents
2018, Neuroscience ResearchVagal afferent activation suppresses systemic inflammation via the splanchnic anti-inflammatory pathway
2018, Brain, Behavior, and ImmunityVagus nerve stimulation: Potential for treating chronic wounds
2024, Wound Repair and Regeneration